Detailed narrative
Clinical Model Resilience and Profitability Maturation
Alignment Healthcare demonstrated the strategic and operational advantages of its clinically centric model in FY25, transforming from near breakeven in adjusted EBITDA in 2024 to $110 million in 2025. This was achieved despite significant industry disruption🌐, including the V28 risk model phase-in, Part D program redesign, and broad utilization pressures. The company's model, focused on delivering high-quality care at lower costs, enabled margin expansion while competitors faced challenges, reinforcing confidence in its ability to win in any rate environment.
Ex-California Market Expansion and Star Ratings Success
The company successfully replicated its model beyond California, more than doubling ex-California membership to 38,000 members by December 2025, representing 16% of total membership. This growth was driven by leading with quality, evidenced by a 5-star plan in North Carolina for the third consecutive year, two 5-star plans in Nevada, a 4.5-star plan in Texas, and a 4-star plan in Arizona. The portability of the Care Anywhere clinical model and scalability of health plan operations are key to unlocking growth potential in these markets.
2026 AEP Results and Responsible Growth Strategy
Alignment Healthcare grew to 275,300 health plan members in January 2026, a 31% year-over-year increase, with 23% growth in California and over 80% growth in ex-California counties. The company focused on responsible growth through bid design and sales strategy, achieving a nearly 20% improvement in AEP voluntary disenrollment and sourcing approximately 80% of gross sales from plan switchers. This balanced approach aims to capitalize on growth opportunities while managing the impact of the final V28 phase-in.
2027 Advance Rate Notice and Regulatory Environment
Management views the 2027 advance rate notice, indicating a 0.9% net increase, as consistent with CMS's focus on program integrity and aligning payments with underlying costs. The company's exposure to unlinked chart reviews is limited (approximately 1% of total HCC value), and it believes its strong clinically-led model and medical cost management competency will allow it to thrive. The current environment is seen as creating a more level playing field, allowing Alignment's distinct care management model to shine.
AI Investments and Operational Efficiency
The company plans targeted investments in AI workflows to improve administrative efficiency and enhance its clinical model and new market playbook. Efforts are focused on establishing a unified data architecture and documenting end-to-end workflows to ensure scalable and abrasion-free growth. Potential AI use cases include refining stratification models for Care Anywhere members, improving member services, and leveraging AI for financial reporting and actionable conclusions market by market, with an internal target to increase Care Anywhere engagement from 65% to 75%.
Capital Structure and Free Cash Flow Generation
Alignment Healthcare generated positive free cash flow in 2025, ending the year with $604 million in cash and investments. Subsequent to the quarter, the company closed a $200 million revolving credit facility, described as 'good housekeeping' and not expected to be drawn on in the near term. The increasing positive free cash flow position is intended to support organic growth objectives and further mature the capital structure.